The objective of this experiment was to determine if transcript abundance of genes involved in metabolic pathways in adipose and liver tissue could provide some explanation for the low efficiency with which ME in autumn pasture is used for BW gain. Nonlactating, pregnant (208 ± 19 d of gestation or approximately 75 d precalving) dairy cows (n = 90) were randomly allocated to either a control diet (i.e., offered fresh autumn pasture to maintenance requirements: 0.55 MJ ME/kg of measured metabolic BW [BW 0.75 ] per day) or, in addition to the control diet, 1 of 2 supplement amounts (2.5 and 5.0 kg DM/d) of autumn pasture or 1 of 4 supplementary feeds (i.e., a control and 2 levels of feeding for each of 5 feeds: 11 groups of cows). Along with autumn pasture, evaluated feeds included spring pasture silage, maize silage, maize grain, and palm kernel expeller. Adipose and liver tissues were biopsied in wk 4 of the experiment and transcript abundance of genes involved in metabolic pathways associated with energy metabolism,
INTRODUCTION
The availability of body energy reserves in early lactation affects milk production and reproduction and has been implicated in cow susceptibility to infectious and metabolic diseases during the early postpartum period (Roche et al., , 2013 . Due to the importance of sufficient energy reserves during early lactation, Roche et al. (2009) proposed an "optimal" calving BCS of 3.0 to 3.25 (5-point system [Wildman et al., 1982 , equivalent to 5.0 to 5.5 in the 10-point system [Roche et al., 2004] ), with heifers and second-lactation cows having improved reproduction and indicators of uterine and mammary health when calving at a slightly greater BCS .
Genetic selection for greater milk production has resulted in cows that lose more BCS in early lactation lipolysis, and lipogenesis was determined. Additional feed, irrespective of type, increased BW gain (P < 0.01) and this effect was reflected in the expression of genes in adipose and liver tissue. However, autumn pasture had lower energy-use efficiency than the other feeds. Genes involved in both lipogenesis (ACACA, THRSP, GPAM, GPD1, and LPL) and lipolysis (PNPLA2) were upregulated (P < 0.05) in adipose tissue in response to increased ME intake/kilogram BW 0.75 . Hepatic expression of APOA1 decreased and that of APOB increased (P < 0.05) in cows offered maize grain and maize silage (i.e., starch-containing feeds). In comparison, pasture-fed cows demonstrated a degree of uncoupling of the somatotropic axis, with lower hepatic transcript abundance of both GHR1A and IGF-1 compared with cows offered any of the other 4 feeds. Changes to gene transcription indicate a possible molecular mechanism for the poor BW gain evident in ruminants consuming autumn pasture.
and prioritize milk production ahead of BCS replenishment during mid and late lactation (McNamara and Hillers, 1986a,b; Roche et al., 2006; McCarthy et al., 2007) . This effect is particularly evident in pasturebased dairy systems and Roche et al. (2007) reported a significant difference in the BCS profile of cows fed a total mixed ration compared with cows grazing fresh pasture. In the grazing setting, BCS replenishment was less and cows were significantly thinner at the end of lactation, therefore requiring a faster rate of BCS gain during the dry period during autumn/winter to ensure they attained the recommended calving BCS (Roche et al., 2006 (Roche et al., , 2007 . To achieve this optimal calving BCS, grazing cows are typically offered additional feed (i.e., supplements) during the dry period, such as maize silage (Msil) or pasture silage (Psil), or fermentable-fiber-based concentrate feeds, such as palm kernel expeller (PKE), soyhulls, or dried distillers grains. For improved accuracy of feed budgeting, Mandok et al. (2014) investigated the efficiency with which ME is used for BW gain (k G ). Their results indicated differences between feeds in k G , with fresh autumn pasture (Past) and cracked maize grain (Mgr) having much lower k G compared with Msil, Psil (conserved from spring pasture), and PKE (Mandok et al., 2014) . Given that the balance between lipolysis and lipogenesis resulting in BW and BCS gain is a function of genetics and environment (McNamara and Hillers, 1986a,b; Smith and McNamara, 1990; Roche et al., 2006 Roche et al., , 2009 McCarthy et al., 2007) , it was hypothesized that the low k G of Past and Mgr may be reflected in differences in the transcript abundance of key genes involved in energy metabolism in adipose tissue (e.g., lipolysis, reesterification, and lipogenesis) or hepatic energy metabolism (e.g., gluconeogenesis, lipogenesis, and fatty acid transport).
The objective of this experiment was, therefore, to determine the transcript abundance of genes involved in metabolic pathways in adipose and liver tissue that are associated with BW gain in nonlactating, late-gestation dairy cows that were 1) allocated fresh Past to achieve maintenance requirements or 2) offered Past to maintenance and 1 of 2 levels of additional fresh pasture or 1 of 4 supplementary feeds to gain body condition.
MATERIALS AND METHODS

Experimental Design and Treatments
Experimental work was conducted at the DairyNZ Lye Farm, Hamilton, New Zealand (37°47′ S, 175°19′ E), between April and June 2011. All procedures involving animals were approved by the Ruakura Animal Ethics Committee, Hamilton, New Zealand.
The full experimental protocol was described by Mandok et al. (2014) ; however, the current study used a subset of these cows (n = 90). Briefly, multiparous pregnant (208 ± 19 d of gestation or approximately 75 d prepartum), nonlactating Holstein-Friesian and Holstein-Friesian × Jersey crossbred dairy cows were individually offered their experimental diet in a Calan Gate (American Calan, Northwood, NH) freestall facility (Hamilton, New Zealand). To reduce variability, 2 cohorts were used depending on calving date, where the first cohort was run through the facilities before the second. Both cohorts were allocated to treatments for 39 d: Cohort 1 between 1 April and 10 May (n = 45) and Cohort 2 from 13 May to 21 June (n = 45). Both cohorts were identically managed. Maintenance requirements were calculated as follows: 0.55 kg DM/ kg of measured metabolic BW (BW 0.75 ; NRC, 2001; Nicol and Brookes, 2007) , with an additional allowance of approximately 20 MJ ME/d to allow for pregnancy and activity (Bell et al., 1995; NRC, 2001 ). All cows were individually offered freshly cut pasture to these predicted maintenance requirements and allocated to the treatment groups described below.
Cows were randomly assigned to 1 of 11 treatment groups: a control group (n = 5/cohort) offered freshly cut Past to estimated requirements for maintenance, pregnancy, and activity or the control allocation plus 1 of 2 amounts of 1 of 5 feeds (i.e., supplement groups; n = 4/treatment group in each cohort). Supplement groups received 2.5 kg DM/d [LOW] or 5.0 kg DM/d [HIGH] of Past, Psil, Msil, PKE, or Mgr (Table 1) . The nonpasture feeds were offered first at approximately 0800 h followed by the cows' maintenance diet. The control and Past cows were offered their total allocation of pasture at 0800 h. After feed was consumed (approximately 7 h), all cows were released onto a bare loafing paddock until the following morning. Cows had unrestricted access to water.
Dry Matter Intake
Feeding regimes and sampling are detailed in Mandok et al. (2014) . Briefly, daily feed offered and refused was recorded for each cow. Representative samples of all offered feeds were collected at every feeding. Pasture refusal samples were bulked across cows daily; refusal samples of the other feeds were collected on an individual cow basis. Aliquots of all feed samples (i.e., offered and refused) were dried in triplicate at 95°C for 48 h to determine DM content and used to calculate individual DMI as kilograms DM offered minus kilograms DM refused.
Feed Description
Permanent pastures (2 to7 yr old) growing on a shallow peat soil were mechanically harvested daily; cutting height was approximately 50 mm. The harvested pasture was typical of that offered to nonlactating cows in grazing systems (i.e., pasture mass of 3,000 to 4,000 kg of DM/ha). It comprised perennial ryegrass (Lolium perenne L.; varieties Bronsyn AR1 and AR37; 82% DM), white clover (Trifolium repens; 5% DM), dead herbage (7% DM), and weed species (5% DM; mainly Plantago major, Ranunculus repens, and Crepis capillaris). Pasture silage was made from spring pastures botanically similar to the previous description. The pasture was precision chopped and a 24-h wilt inoculant (Pioneer 1127; Genetic Technologies, Auckland, New Zealand) was added. The Msil (hybrid Pioneer 0791) was finely chopped and kernel processed to crack the grains. An inoculant (Pioneer 11C33) was added to the silage.
A sample of feed offered was collected daily in duplicate (2 × 150 g), dried (72 h at 60°C), ground to pass through a 2.0-mm sieve (Christy Lab Mill, Suffolk, UK), and bulked on a weekly basis for feed composition analysis. Nutrient composition was assessed by wet chemistry (Dairy One, Ithaca, NY) and the ME content of the feed predicted from equations (NRC, 2001) . The DM content, nutrient composition, and ME content of feeds are presented in Table 1 .
Body Weight and Body Condition Score
Body weight and BCS (10-point scale in which 1 = emaciated and 10 = obese; Roche et al., 2004) were recorded 2 d before the start of the experiment and 3 d after the experiment. Body condition score was determined by 1 experienced assessor on 1 d each week throughout the trial. Cows were weighed 3 d each week (Monday, Wednesday, and Friday) at approximately 0730 h (before feeding).
Blood Sampling and Blood Analysis
On 1 d each week, blood samples (2 × 10 mL) were collected by coccygeal venipuncture into evacuated tubes containing sodium heparin (blood metabolite analysis) or EDTA (insulin and leptin analysis) to prevent blood coagulation. Whole blood was centrifuged at 3,000 × g at 4°C for 12 min and plasma was harvested, aliquoted into tubes, and stored at -20°C. Before analyses, plasma samples underwent an acid-ethanol cryoprecipitation extraction (Breier et al., 1991) . Analyses for plasma NEFA (colorimetric method) and glucose (hexakinase method) were performed on a modular P800 analyzer (Roche, Basel, Switzerland) at 37°C by Gribbles Veterinary Pathology Ltd. (Hamilton, New Zealand). The interand intra-assay CV were <2% for both assays. Insulin was measured in duplicate using a porcine insulin RIA kit (PI-12K; Millipore, Billerica, MA), with a minimum detection limit of 0.30 microunits/mL. Leptin was measured using a "multispecies" RIA kit (XL-85K; Millipore), with a minimum detection limit of 1.685 ng/mL. Insulin-like growth factor 1 was measured in duplicate using a human sandwich ELISA kit (Duoset DY291; R&D Systems, Minneapolis, MN). Plasma samples from wk 4 that coincided with the tissue biopsies are presented in this paper.
Tissue Sampling, RNA Extraction, and mRNA Analyses Collection of Liver and Adipose Tissue Samples. Tissue biopsy samples were obtained from each animal during wk 4 of the experiment. Subcutaneous adipose biopsies were collected posterior to the shoulder blade and approximately 100 mm ventrally from the withers. The site was clipped and cleansed with iodine before a local anesthetic (2% lignocaine; Lopaine; Ethical Agents, Auckland, New Zealand) was administered. A 30-mm incision was made through the depth of the skin, where approximately 100 mg of adipose tissue was removed using forceps and a scalpel.
The site of liver biopsy was on the right rib cage at the 11th intercostal space, as described by Lucy et al. (2009) . The area was clipped, cleansed, and incised in the same manner as the adipose biopsy site and liver tissue samples were removed using a biopsy punch (230 mm length and 3 mm diameter; Rhone-Poulenc Rorer NZ Ltd., Auckland, New Zealand). All adipose and liver samples (approximately 200 mg) were divided in 2, immediately placed in microcentrifuge tubes, snap-frozen in liquid nitrogen, and stored at -80°C until analysis.
Ribonucleic Acid Extraction. Adipose tissue (80 mg) and liver tissue (30 mg) samples were placed in Qiagen RLT lysis buffer (Qiagen GmbH, Hilden, Germany) in 2-mL homogenization tubes containing 3 ball bearings of 3 mm diameter (Farrell Bearings Ltd., Hamilton, New Zealand) and homogenized using a TissueLyser II (Qiagen GmbH). Chloroform (200 μL) was added to adipose tissue homogenates and centrifuged at 12,000 × g for 15 min at 4°C and the aqueous phase was removed for total RNA extraction. Total RNA from adipose and liver tissue was extracted using a Qiagen RNeasy Mini kit according to manufacturer's instructions (Qiagen GmbH). All samples were deoxyribonuclease treated using the Ambion DNA-free kit (Life Technologies, Auckland, New Zealand). The quantity of RNA was determined by spectrophotometry using a Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE) and RNA integrity was confirmed using an Agilent 2100 Bioanalyzer with an RNA 6000 Nano LabChip kit (Agilent Technologies, Santa Clara, CA). Ribonucleic acid samples had an RNA integrity number (RIN) cut off of 5.5 with an average RIN (±SD) of 6.4 ± 0.9 and 6.8 ± 0.5 for adipose and liver tissue, respectively. Samples of high-enough quality were used for gene expression analysis and the final number of adipose and liver RNA samples were n = 82 and n = 84, respectively; these were stored at -80°C pending use in future assays.
Complementary DNA Synthesis and Quantitative Real-Time PCR. Total RNA (1 or 2 μg of RNA from adipose and liver tissue samples, respectively) was reverse transcribed using a Superscript III Supermix kit (Life Technologies) with random pentadecamer primers at a final concentration of 27 μM. Reversetranscriptase negative controls were also generated by excluding the enzyme, and cDNA samples were stored at -20°C. Quantitative reverse-transcriptase PCR (RTqPCR) was used to analyze the expression of genes involved in key metabolic pathways in adipose and liver tissue (Table 2) . Quantitative reverse-transcriptase PCR was undertaken using a Roche LightCycler 480 instrument and Roche reverse-transcriptase (RT-) PCR master mix (LightCycler 480 Probes Master) in combination with Roche Universal Probe Library (UPL) assays. Assays were designed using publicly available bovine gene sequences (National Center for Biotechnology Information; http://www.ncbi.nlm. nih.gov) and Roche UPL design software to span an intron-exon boundary to prevent amplification of genomic DNA. Assay specificity was tested using the basic local alignment search tool (BLAST; http://blast. ncbi.nlm.nih.gov/Blast.cgi). The assay specifications are presented in Table 2 . Each RT-qPCR reaction (to- 1 COX4I1 = cytochrome c oxidase subunit IV isoform 1; EIF3K = eukaryotic translation initiation factor 3, subunit K; GAPDH = glyceraldehyde-3-phosphate dehydrogenase; RPS15A = ribosomal protein S15a; ACACA = acetyl-CoA carboxylase alpha; APOA1 = apolipoprotein A-I; APOB = apolipoprotein B; GHR1A = growth hormone receptor 1a; GPAM = glycerol-3-phosphate acyltransferase; GPD1 = glycerol-3-phosphate dehydrogenase 1 (soluble); IGF-1 = insulin-like growth factor 1; LEP = leptin; LIPE = hormone-sensitive lipase; LPL = lipoprotein lipase; PC = pyruvate carboxylase; PCK1 = phosphoenolpyruvate carboxykinase 1 (soluble); PLIN1 = perilipin; PNPLA2 = patatin-like phospholipase domain containing 2; PPARG = peroxisome proliferator-activated receptor gamma; SCD = stearoyl-CoA desaturase; THRSP = thyroid hormone responsive (SPOT14 homolog, rat).
2 http://www.ncbi.nlm.nih.gov.
3 Primer sequences are shown 5′ to 3′. Possible endogenous control genes were tested across all samples for each tissue type, with suitability determined using GeNorm gene expression stability (M-value, < 1.5; Vandesompele et al., 2002) and Normfinder (Andersen et al., 2004) . Roche LightCycler 480 software was used to perform quantification analysis of gene expression, which was initially achieved using the "relative standard curve secondderivative maximum" method with a 6-point standard curve of serial dilutions of cDNA ranging from 3.33 × 10 -1 to a final dilution of 1.37 × 10 -3 . Advanced relative quantification analysis of gene expression was then completed using normalization factors calculated from the geometric mean of the 2 endogenous control genes for each sample. The endogenous control genes with the lowest inter-and intragroup variability were eukaryotic translation initiation factor 3 subunit κ and ribosomal protein S15a in adipose tissue samples and cytochrome c oxidase subunit IV isoform 1 and glyceraldehyde-3-phosphate dehydrogenase in liver tissue samples.
Calculations and Statistical Analysis
GenStat 14.1 (VSN International, Hemel Hempstead, UK) was used for all statistical analyses. Metabolizable energy intake (MJ) and BW gain were combined to calculate the k G for each supplement type, taking into account the BW gain of each cow relative to her additional intake of ME. Because of possible substitution effects, the additional DMI for each cow was calculated by subtracting the mean control intake for the cohort from the DMI of each cow in the cohort.
Efficiency of use of energy for BW gain was calculated by initially using regression analysis for each cohort and each supplement type to estimate the slope of the line fitted to BW gain for each cow as the dependent variable and additional megajoules of ME intake as the independent variable. The model used had a common intercept (representing the BW change for no additional intake) for the 5 supplement types but different slopes for each supplement. This was repeated for each cohort giving 2 estimates of the slope for each supplement type (1 from each cohort); the model used was
in which i is the cohort (i.e., 1-2), j is the supplement type, and k is the cow; y ijk is the BW gain of cow ijk on supplement j of cohort i, a i is the intercept for cohort i (i.e., the BW change, if not supplemented), b ij is the slope for supplement j in cohort i, intake ijk is ME intake in megajoules for cow ijk, c i is the ME intake in megajoules for the control cows in cohort i, and e ijk is the error term. The 10 slopes (b ij ; kg BW/MJ ME intake) were then analyzed in a weighted analysis using linear models that included cohort and supplement type as fixed effects and the square reciprocal of the SE of the fitted sloped as weights.
The k G was calculated as 1/(slope × 25), because 25 MJ is the average NE contained in 1 kg of BW (Holmes et al., 2002) .
Gene expression variables, blood metabolites, and hormones were analyzed using mixed models after log 10 -transformation (with the exception of β-hydroxybutyrate [BHBA] and glucose) because of heterogeneity of variance. Cohort and treatment were included in the model as fixed effects and cow as a random effect. The experimental unit was cow. In addition, the analysis was rerun with treatment split into factors (i.e., as a control + 5 × 2 factorial) to test control vs. supplemented, effect of supplement type, effect of supplement amount, and the interaction of supplement type with supplement amount to aid interpretation of treatment effects. Data are presented as least squares means and the SED for the main effects. Pooled within treatment correlations were determined between each gene expression variable after log 10 -transformation and ME intake using regression analysis, including cohort and treatment as factors, and wk 4 ME intake in the model. Differences were declared significant at P < 0.05 and tendency was defined as P = 0.05 > 0.10.
RESULTS
Dry Matter Intake and BW Gain
Summary data for DMI, ME intake, BW gain, and estimates for k G are presented in Table 3 . There were no interactions between supplement type and supplement amount (P > 0.1); therefore, only main effects are presented. Cows offered additional feed above maintenance had greater total daily DMI (kg/d), ME intake, and BW and BCS gain than control cows (P < 0.01). Daily BW gain was greater in cows offered supplement and average ME requirements/kilogram BW gain ranged from 64 to 90 MJ/d, depending on feed type. As a result, estimated efficiency of use of ME for BW gain ranged from 0.28 to 0.39.
Blood Metabolites
The effects of treatment on the circulating concentration of key metabolites associated with energy balance at wk 4 are presented in Table 3 . There were no significant interactions between supplement type and supplement amount (P > 0.10). Concentrations of NEFA were less and insulin greater in cows offered supplement compared with control cows. Furthermore, cows offered Mgr had the lowest plasma NEFA compared with the other feeds, and NEFA concentration tended to be less in Msil and Psil cows than cows receiving PKE and Past. Although average blood BHBA concentration was not different between control and supplemented groups (P = 0.25), supplement type affected BHBA concentration, with cows offered Mgr having higher BHBA concentrations than cows receiving Psil. Blood IGF-1 concentrations were not affected by supplement amount (P = 0.21) but differed between supplement types, such that IGF-1 concentrations were greater in cows offered Mgr compared with cows offered Past and PKE. There were no treatment effects on plasma leptin concentration.
Transcript Abundance in Adipose Tissue
The effects of treatment on transcript abundance of genes in adipose tissue are presented in Table 4 . There was a tendency for increased expression of genes involved in fatty acid synthesis and lipogenesis when cows were offered supplementary feeds; for example, the transcript abundance of glycerol-3-phosphate acyltransferase (GPAM), glycerol-3-phosphate dehydrogenase 1 (GPD1), acetyl-CoA carboxylase α (ACACA), stearoyl-CoA desaturase (SCD), thyroid hormone-inducible hepatic protein (THRSP), lipoprotein lipase (LPL), and leptin (LEP) in adipose tissue was greater in cows offered supplementary feeds com- Table 3 . Average daily DMI and ME intake, daily BW and BCS gain, the efficiency with which ME is used for BW gain (k G ), and plasma concentrations of metabolites and hormones indicative of energy status in nonlactating dairy cows at 208 d ± 19 d (mean ± SD) pregnant and offered their estimated maintenance energy requirements as fresh pasture (control) pared with control cows. Supplement amount did not affect the expression of genes involved in fatty acid synthesis, uptake, or reesterification; however, expression of THRSP and LEP tended (P = 0.11 and P = 0.10, respectively) to be greater in cows offered a HIGH relative to a LOW amount of supplement. Transcript abundance of THRSP was greater in adipose tissue from cows supplemented with Mgr and Msil compared with cows offered additional pasture. There was no effect of supplement level or type on the expression of lipolytic-regulating genes (i.e., hormonesensitive lipase [LIPE] and perilipin [PLIN1]). Patatinlike phospholipase domain containing 2 (PNPLA2) expression (P = 0.05) was greater depending on supplement type, with greater expression in cows offered Psil or Mgr supplementation compared with cows offered additional pasture. There were no interactions between supplement type and supplement amount (P > 0.30).
Transcript Abundance in Liver Tissue
The effects of treatment on hepatic transcript abundance are presented in Table 5 . There were no interactions between supplement type and supplement amount Table 4 . Relative mean mRNA expression of key lipolytic and lipogenic genes in adipose tissue of nonlactating, pregnant dairy cows at 208 d ± 19 d (mean ± SD) pregnant for each treatment group. Treatments included 2 feeds offered in 2 amounts (2.5 kg DM/d [LOW] and 5.0 kg DM/d [HIGH] ) in addition to a base intake of fresh pasture (control). Transcript abundance for each supplementation group is presented as means (Log 10 ) of treatment amounts relative to eukaryotic translation initiation factor 3 and subunit κ and ribosomal protein S15a endogenous control genes with SED between means compared with controls as well as means of feeds for each supplement (Suppl.) amount. The least significant difference was used to determine significance between supplement types calculated using a post hoc Tukey test. There were no interactions (P > 0.3) between supplement type and amount. Gene expression is back transformed in parentheses. 1 ACACA = acetyl-CoA carboxylase alpha; GPAM = glycerol-3-phosphate acyltransferase; GPD1 = glycerol-3-phosphate dehydrogenase 1 (soluble); LEP = leptin; LIPE = hormone-sensitive lipase; LPL = lipoprotein lipase; PCK1 = phosphoenolpyruvate carboxykinase 1 (soluble); PLIN1 = perilipin; PNPLA2 = patatin-like phospholipase domain containing 2; PPARG = peroxisome proliferator-activated receptor gamma; SCD = stearoyl-CoA desaturase; THRSP = thyroid hormone responsive (SPOT14 homolog, rat).
2 PKE = palm kernel expeller.
(P > 0.20); therefore, only main effects are presented. Hepatic transcript abundance of genes involved in fatty acid synthesis increased with greater energy intake; ACACA and SCD expression was greater in cows offered additional supplementation compared with control cows. In addition, expression of ACACA tended (P = 0.09) to be greater in HIGH vs. LOW supplement allocations. Hepatic expression of THRSP was greater in cows offered additional feeds relative to control cows, with the exception of additional Past, and tended to be greater (P = 0.06) in the HIGH allocation. There also appeared to be an effect of supplement type on the hepatic transcription of genes encoding proteins involved in fatty acid synthesis, with cows consuming additional Past having lower expression than cows offered the other feeds. Cows offered PKE had greater SCD expression than cows offered additional Past and there was a tendency (P = 0.05) for SCD expression to be greater in cows fed Msil compared with Past. There was also a trend (P = 0.09) for greater THRSP expression in liver tissue from Psil cows relative to Past cows.
The expression of apolipoprotein genes was affected by feeding treatment. Expression of apolipoprotein A-I (APOA1) was lower in supplemented cows compared with control cows, whereas the expression of apolipoprotein B (APOB) was greater. Expression of APOA1 was lower in Mgr cows compared with those offered PKE, whereas expression of APOB tended to be greater in Msil and Mgr supplemented cows compared with cows offered additional low-starch feeds (i.e., Past, PKE, and Psil).
In general (P < 0.10), cows offered additional pasture (Past) had lower expression of genes involved in the Table 5 . Relative mean mRNA gene expression of somatotropic and lipogenic genes in liver tissue of nonlactating, pregnant dairy cows 208 ± 19 (mean ± SD) days pregnant for each treatment group. Treatments include 5 feeds offered in 2 amounts (2.5 kg DM/d [LOW] and 5.0 kg DM/d [HIGH] ) in addition to a base intake of fresh pasture (control). Transcript abundance for each supplementation group is presented as means (Log 10 ) of treatment amounts relative to cytochrome c oxidase subunit IV isoform 1 and glyceraldehyde-3-phosphate dehydrogenase endogenous control gene expression with SED compared with controls as well as means of feeds for each supplement (Suppl.) amount. The least signigicant difference was used to determine significance between supplement types calculated using a post hoc Tukey test. There were no interactions (P > 0.2) between supplement type and amount. Gene expression is back transformed in parentheses. somatotropic axis (GHR1A and IGF-1) than those fed the other supplementary feeds. There was no effect of treatment on expression of pyruvate carboxylase (PC) and phosphoenolpyruvate carboxykinase 1 (PCK1).
Relationship between ME Intake and Transcript Abundance
The proportion of the variation in transcript abundance for key genes in adipose and liver tissue metabolism that is explained by ME intake/kilogram BW 0.75 is presented in Table 6 . Transcript abundance of lipogenic genes (ACACA, LPL, GPAM, GPD1, and THRSP) was greater or tended (P = 0.07) to be greater (SCD) with increasing ME intake/kilogram BW 0.75 in adipose tissue. Additionally, expression of the adipogenic gene (LEP) and lipolytic-related gene (PNPLA2) was greater and expression of the glyceroneogenic gene (PCK1) as well as the transcription factor PPARG tended (P = 0.06) to be greater in adipose tissue with increasing energy intake.
Metabolizable energy intake was not associated with the expression of somatotropic, lipid transport, or gluconeogenic genes in liver tissue. However, the expression of THRSP increased with ME intake/kilogram BW 0.75 , and there was a trend (P < 0.10) for a positive relationship between ME intake/kilogram BW 0.75 and SCD expression.
DISCUSSION
The effects of supplementary feeding on the expression of genes involved in key physiological pathways in liver and adipose tissue were assessed in nonlactating, pregnant dairy cattle. Supplementation increased the expression of lipogenic genes in hepatic and adipose tissue, reflecting changes to the physiological processes underlying BW gain. Evident effects of feed type on the expression of measured genes reflect the poor efficiency with which ME from Past is used for BW gain.
Lipogenesis is Increased with ME Intake
Genes involved in lipogenesis in both adipose and hepatic tissue increased expression with additional feeding. For instance, increasing the ME intake of dry cows upregulated fatty acid synthesis genes (ACACA, SCD, and THRSP) in both tissues, indicating an increase in de novo fatty acid synthesis in these animals. Results were consistent with an increase in adipose mass with increasing supplementation. Synchronized transcription of the genes reported here (ACACA, GPAM, SCD, and THRSP) in adipose tissue is responsible for the process of lipogenesis, including fatty acid synthesis and esterification, which results in adipose deposition and is positively correlated with BCS (Otto et al., 1991; Loor, 2010) . Indeed, feeding supplements increased BW and BCS gain and was associated with greater adipose expression of the adiposity-related gene, LEP, as well as reduced circulating concentrations of NEFA. In addition, altered hepatic transcription profiles in overfed prepartum dairy cows have been described previously by Loor et al. (2006) . Consistent with the results presented here, expression of genes encoding triacylglycerol (TAG) synthesis enzymes were increased in their study when compared with feed-restricted cows. Furthermore, Ji et al. (2012) 1 ACACA = acetyl-CoA carboxylase alpha; GPAM = glycerol-3-phosphate acyltransferase; GPD1 = glycerol-3-phosphate dehydrogenase 1 (soluble); LEP = leptin; LIPE = hormone-sensitive lipase; LPL = lipoprotein lipase; PCK1 = phosphoenolpyruvate carboxykinase 1 (soluble); PLIN1 = perilipin; PNPLA2 = patatin-like phospholipase domain containing 2; PPARG = peroxisome proliferator-activated receptor gamma; SCD = stearoyl-CoA desaturase; THRSP = thyroid hormone responsive (SPOT14 homolog, rat).
2 ACACA = acetyl-CoA carboxylase alpha; APOA1 = apolipoprotein A-I; APOB = apolipoprotein B; GHR1A = growth hormone receptor 1a; IGF-1 = insulin-like growth factor 1; PC = pyruvate carboxylase; PCK1 = phosphoenolpyruvate carboxykinase 1 (soluble); SCD = stearoyl-CoA desaturase; THRSP = thyroid hormone responsive (SPOT14 homolog, rat).
ly reported that ACACA and SCD expression increase in overfed dry cows at -10 d relative to parturition.
Increased fatty acid synthesis and lipogenesis are also supported by expression changes in genes involved in fatty acid transport and lipolysis. For example, the increased expression of LPL in adipose when cows were offered supplements indicates increased hydrolysis of lipoproteins (e.g., low-density lipoprotein [LDL]), which enables lipid uptake into this tissue. This effect of supplementary feeding is supported by Ji et al. (2012) , who also demonstrated an increase in LPL expression with overfeeding in nonlactating cows. Furthermore, increased intracellular fatty acid, due to LDL hydrolysis facilitated by LPL, is supported by increased expression of GPAM and GPD1 with supplementation. Glycerol-3-phosphate dehydrogenase 1 contributes to TAG synthesis in obesity models and fatty acids necessary for the esterification of glycerol-3-phosphate are thought to be derived from TAG in circulating lipoproteins formed in the liver (Swierczynski et al., 2003) . In summary, the transcript abundance data from adipose tissue are consistent with greater lipogenesis with increasing ME intake, supporting the effect of feed treatment on BW gain.
Feed Type Affects Fatty Acid Metabolism
Triacylglycerol molecules are transported from the liver via apolipoprotein B (APOB)-containing LDL particles. In the experiment reported here, hepatic APOB expression was upregulated when cows were offered a high starch supplement (i.e., Mgr and Msil) relative to a low-starch supplement (i.e., Past, PKE, and Psil), indicating that LDL-facilitated TAG transport to adipose for storage is increased when cows are fed starch-or nonfiber carbohydrate (NFC)-based feeds. Consistent with this observation, guinea pigs offered feeds differing in carbohydrate composition had increased plasma APOB associated with verylow-density lipoprotein particles in treatment groups consuming a high-starch diet (Fernandez et al., 1996) . There was also lower APOA1 expression in Mgr, Msil, and Psil treatment groups in the current experiment. This result indicates reduced reverse cholesterol transport from peripheral cells to liver for catabolism, as APOA1-containing high-density lipoprotein particles are involved in transporting cholesterol from peripheral tissue to the liver (reviewed in Fredenrich and Bayer, 2003) . These effects are consistent with the greater BW and BCS gain evident in cows offered supplementary feeds high in starch.
Results are consistent with evidence that TAG lipolysis in adipose tissue occurs via a reaction involving the patatin-like phospholipase domain containing 2 protein (PNPLA2),, as PNPLA2 expression increased with increasing ME intake/kilogram BW 0.75 without a change to LIPE or PLIN1 expression. Duncan et al. (2007) discusses the role of PNPLA2 in white adipose tissue, leading to the conclusion that PNPLA2 is considered the rate-limiting enzyme for TAG hydrolysis. Similar results were reported in prepartum overfed cows, with increased PNPLA2 expression and no effect on the expression of LIPE or PLIN1; this is supporting evidence that lipolysis is tightly regulated during overfeeding through PNPLA2 activity (Ji et al., 2012) . Increased lipolysis concurrent with lipogenesis may appear paradoxical; however, lipolysis is required to promote lipogenic gene transcription through fatty acidactivation of peroxisome proliferator-activated receptor gamma (PPARγ; Zechner et al., 2012) . Activation of PPARG signaling is indicative of adipogenesis and is consistent with previously discussed transcription results, as PPARG regulates the expression of many of the lipogenic genes involved in adipocyte metabolism and differentiation. Collectively, these results indicate that there are changes to lipid transport that facilitates lipogenesis and, to a lesser extent, lipolysis in adipose tissue with increasing ME intake that ultimately results in net adipose tissue deposition (adipogenesis). The type of feed, however, does not have a consistent effect on this response.
Effect of Feed Type on Expression of Genes Involved in Gluconeogenesis
Composition of supplementation and supplement amount altered circulating glucose concentrations but not transcript abundance of the hepatic gluconeogenic genes PCK1 and PC. Transcription of genes involved in gluconeogenesis were expected to increase, as increased feeding and the provision of NFC would be expected to increase ruminal propionate production and thereby increase hepatic gluconeogenesis (Doelman et al., 2012) . In the present study, there was no effect of supplementing a starch-based concentrate to grazing cows on PC or PCK1 expression. A possible reason for the lack of effect is a failure of overfed, nonlactating cows to respond to gluconeogenic stimuli; this is consistent with published results indicating that a high-energy diet during the precalving period suppresses gluconeogenesis through a feedback mechanism (Loor et al., 2006; Selim et al., 2014) .
Transcriptional Evidence that Metabolizable Energy in Autumn Pasture is Used with Low Efficiency
The use of Past as the sole diet altered measured components of the somatotropic axis. Transcript abun-dance of hepatic GHR1A and IGF-1 and plasma IGF-1 concentrations were lower in Past cows compared with cows offered other feeds. Although reduced expression of GHR1A and IGF-1 in liver is reported to occur under normal circumstances immediately postpartum in dairy cattle to enable nutrient partitioning to the mammary gland (Lucy et al., 2009; Grala et al., 2010) and under feed restriction circumstances during established lactation (McGuire et al., 1992; Breier, 1999) , this is the first time, to our knowledge, that the somatotropic axis has been reported to experience a degree of uncoupling in a nonlactating cow in positive energy balance. This requires further investigation but is consistent with the phenomenon of "ill thrift" evident in both meat and dairy pasture-fed animals offered Past, wherein stock grow more slowly than expected when offered adequate feed allocation (Lancashire et al., 1966; Brewer and Calder, 1971; Macrae et al., 1985) . These data indicate that one of the reasons for the inefficiency of energy use from Past for BW gain may be due to the uncoupling of the somatotropic axis, an important factor in anabolic processes.
Effect of Maize Grain on Blood Metabolites and Gene Expression
Cows fed Mgr had the greatest increase in BCS and BW of all offered feeds and also had lower NEFA and higher IGF-1 blood constituents relative to cows consuming other feeds. These effects occurred despite the putative low estimated efficiency of gain (k G ) of Mgr in the late gestation nonlactating dairy cow model (Mandok et al., 2014) . Transcriptional results relating to lipogenesis/lipid accumulation in adipocytes are consistent with the measured increases in BCS and BW in this treatment. Genes involved in lipogenesis (ACACA, GPAM, LPL, SCD, and THRSP) were upregulated in the Mgr supplementation group as well as transcription of LEP, indicating fatty acid synthesis and adipogenesis, as leptin concentrations are correlated with adipose tissue deposition (Friedman and Halaas, 1998) . Surprisingly, however, there were no changes to plasma leptin concentrations across treatment groups; this may have been a consequence of the single time-point sampling method used.
The positive effect of Mgr probably reflects the greater ME intake in this treatment relative to the other feeds. Cows offered Mgr had greater plasma insulin and IGF-1 concentrations and decreased plasma NEFA concentrations compared with controls, which supports previous studies regarding gene transcription in prepartum cows fed grain diets (Janovick et al., 2009 ). For example, several studies have reported greater plasma insulin concentration (Rukkwamsuk et al., 2000; Dann et al., 2005 Dann et al., , 2006 Rabelo et al., 2005; Loor et al., 2006) and decreased NEFA concentrations (Minor et al., 1998; Rabelo et al., 2001; Oba and Allen, 2003) in cows consuming diets with increased grain content, consistent with findings in this study. Janovick et al. (2009) reported transcriptional profiles in adipose from prepartum cows overfed energy in the form of a high-grain diet that suggested greater availability of cellular energy in response to glucose influx; this could explain both the lower NEFA concentrations, due to the effects of insulin on lipolysis or reesterification (Rabelo et al., 2001) , and the greater ACACA and GPAM expression.
The transcription profiles presented may help explain the low estimated k G of Mgr reported by Mandok et al. (2014) . The k G calculation assumes a constant NE content of gain (i.e., 25 MJ of NE in each 1.0 kg BW gain) irrespective of supplement type. The transcript abundance results presented here indicate possible differences in the composition of BW gain with different feed types. Increased expression of lipogenic-related pathways and TAG transport pathways could indicate a greater ratio of fat to protein in BW gain with NFCbased feed ingredients, thereby increasing the NE content of each kilogram of BW gain and, in so doing, reducing the estimated k G . This is plausible, as Mgr would be expected to increase ruminal propionate production (Bauman et al., 1971) , stimulating subsequent insulin release (Harmon, 1992) and increased lipogenesis (Sutton et al., 1988) , thereby aligning the transcription profiles. If this is true, the approach to estimating k G used here would underestimate the efficiency with which ME is used for high-starch feeds and could explain, at least in part, the lower estimated k G for Mgr in late gestation dairy cows (Mandok et al., 2014) . Nonetheless, the k G for Mgr estimated here is 30% less than that used in NRC (2001) . Such a difference is unlikely to be explained by an underestimation of NE content of gain alone. Mandok et al. (2014) hypothesized that the low k G for Mgr could be due to a greater partitioning of ME to conceptus metabolism in late gestation. The results indicate a need for further research to determine if supplement type influences the composition of BW gain and if such composition differences influence the effect of calving BCS on future milk production and reproduction .
In summary, ME intake and supplementary feed composition affect the transcript abundance of genes involved in several metabolic pathways in adipose and liver tissue of nonlactating pregnant dairy cows. Increasing ME intake up to 5.0 kg DM/cow above requirements for maintenance, pregnancy, and activity during the dry period increased the transcript abun-dance of ACACA, SCD, THRSP, LPL, GPD1, GPAM, and LEP in adipose tissue and increased the expression of ACACA, SCD, THRSP, and APOB but decreased the expression of APOA1 in liver tissue. The pathways discussed help explain the molecular mechanism of BW and BCS gain resulting from increased ME intake and supplementary feeding. Collectively, this is achieved by transcriptional changes of genes involved in cellular processes of BW gain in both adipose and liver tissue, including lipogenesis, lipid mobilization, and the somatotropic axis. Furthermore, the results also identify some molecular mechanisms that possibly explain the "ill thrift" phenomenon associated with autumn pasture.
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